• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by CME Group Inc.

    4/24/25 4:09:29 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0000925105
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    CME GROUP INC.
    SEC File Number
    001-31553
    Address of Issuer
    20 South Wacker Drive
    Chicago
    ILLINOIS
    60606
    Phone
    (312) 930-1000
    Name of Person for Whose Account the Securities are To Be Sold
    LARRY G GERDES
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Class A Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    2000528202.6036035417404/24/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Class A Common01/31/2022Compensation for Past ServicesIssuerCheckbox not checked7501/31/2022Services Rendered
    Class A Common06/30/2022Compensation for Past ServicesIssuerCheckbox not checked100806/30/2022Services Rendered
    Class A Common06/30/2021Compensation for Past ServicesIssuerCheckbox not checked91706/30/2021Services Rendered

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    04/24/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Larry G. Gerdes

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CME alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    6/21/2024$206.00 → $187.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:11:41 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Shepard William R bought $71,995 worth of Common Stock Class A (274 units at $262.62), increasing direct ownership by 0.48% to 2,443 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 7:19:14 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 6:55:07 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Maloney Patrick W was granted 532 units of Common Stock Class A, increasing direct ownership by 15% to 4,098 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:36:05 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Ford Harold Eugene Jr. was granted 532 units of Common Stock Class A, increasing direct ownership by 34% to 2,091 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:35:56 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Cook Elizabeth A was granted 532 units of Common Stock Class A (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:35:46 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CME Group upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00

      4/8/25 9:08:11 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Raymond James with a new price target

      Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00

      3/10/25 7:18:35 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group downgraded by Citigroup with a new price target

      Citigroup downgraded CME Group from Buy to Neutral and set a new price target of $250.00 from $255.00 previously

      1/6/25 7:45:08 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year

      Record Europe, Middle East and Africa (EMEA) ADV of 6.7M, up 15% in Q2 2025Record Asia Pacific (APAC) ADV of 2.2M, up 30% in Q2 2025LONDON and SINGAPORE, July 10, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 9.2 million contracts in Q2 2025, up 18% year over year. Reflecting all trading reported outside the United States, this growth was driven by record quarterly ADV in EMEA and APAC. Quarterly international records were achieved in Interest Rate, Equity Index, Energy, Agricultural and Metals products up 14%, 38%, 23%, 3% and 14% respectively.  "During this period of

      7/10/25 3:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures

      CHICAGO, July 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it has completed its first physical delivery cycle of Hard Red Spring Wheat futures, with 182 contracts delivered on July 1, 2025, the first delivery date since the product's April 14 launch. "Completion of the first delivery cycle is another important milestone for our new Hard Red Spring Wheat futures contract," said John Ricci, Managing Director and Global Head of Agricultural Products at CME Group. "The contract is already providing value, with over 460,000 contracts traded since the April launch as more industry participants turn to CME Group to manage all aspects of wheat

      7/2/25 11:39:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Sets Record Quarterly and June ADV, Driven by Growth Across Asset Classes

      Record quarterly ADV of 30.2 million contractsRecord quarterly ADV in interest rates, agriculture, metals and SOFR futures Record June ADV of 25.7 million contractsRecord quarterly international ADV of 9.2 million contractsCHICAGO, July 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its Q2 and June 2025 market statistics, with average daily volume (ADV) reaching a new quarterly record of 30.2 million contracts and June ADV reaching a record 25.7 million contracts. In Q2, the company's ADV grew 15% year-over-year, with record quarterly volume in interest rate, agricultural and metals products. CME Group's deeply liquid SOFR futures also hit a q

      7/2/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    SEC Filings

    See more
    • SEC Form 144 filed by CME Group Inc.

      144 - CME GROUP INC. (0001156375) (Subject)

      5/15/25 10:54:52 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CME GROUP INC. (0001156375) (Filer)

      5/9/25 1:06:49 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by CME Group Inc.

      10-Q - CME GROUP INC. (0001156375) (Filer)

      4/30/25 2:50:10 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Financials

    Live finance-specific insights

    See more
    • CME Group Inc. Announces Second-Quarter 2025 Earnings Release, Conference Call

      CHICAGO, June 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the second quarter of 2025 before the markets open on Wednesday, July 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions. A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing to

      6/17/25 4:04:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Declares Quarterly Dividend

      CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu

      5/8/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025

      Record revenue of $1.6 billion, up 10% from Q1 2024Record average daily volume (ADV) of 29.8 million contracts, with broad-based growth in every asset classCHICAGO, April 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the first quarter of 2025. The company reported revenue of $1.6 billion and operating income of $1.1 billion for the first quarter of 2025. Net income was $956 million and diluted earnings per common share were $2.62. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.80. Financial results presented on an adjusted basis for the first quarter of 2025 and 2024 exclude certain items, which are

      4/23/25 7:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    See more
    • CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

      CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

      5/9/25 10:29:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Clearing Appoints New Chief Risk Officer

      CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

      4/24/25 4:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sterling Trading Tech Names Julie Armstrong Chief Commercial Officer

      Chicago , April 23, 2025 (GLOBE NEWSWIRE) -- Sterling Trading Tech (Sterling), a leading global provider of technology in order management, risk and margin, and trading, announced today the appointment of Julie Armstrong as Chief Commercial Officer, a newly created role that underscores the firm's commitment to scaling its business globally. This strategic hire signals Sterling's transition into its next phase of accelerated growth, building on recent momentum across new client segments, product innovation, asset expansion, and geographic reach. Armstrong, a recognized industry expert, brings decades of experience in global fintech strategy and revenue generation. She will lead Sterling'

      4/23/25 2:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/24 5:02:29 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/23 2:49:27 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/11/22 3:04:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance